Association Between Smoking with a Molecular Profile of Breast Cancer Smoking and molecular profile of breast cancer

Greetchen Borges de Campos Bólico Ferreira (1), Ildo Borges de Campos Bolico Ferreira (2), Jamile Ahmed Borges Geha (3), Maria Cecília Leite de Moraes (4), Luciano Amorim Meirelles (5), Elias Ferreira Pôrto (6)
(1) health promotion, Adventist University Center of São Paulo, Sao Paolo, Brazil, Brazil,
(2) health promotion, Adventist University Center of São Paulo, Sao Paolo, Brazil, Brazil,
(3) Faculty of Dentistry and Dental Research Center São Leopoldo Mandic, Brazil, Brazil,
(4) Health promotion, Adventist University, São Paulo, Brazil, Brazil,
(5) health promotion, Adventist University Center of São Paulo, Sao Paolo, Brazil , Brazil,
(6) health promotion, Adventist University Center of São Paulo, Sao Paolo, Brazil , Brazil

Abstract

Background: Female breast cancer is one of the causes of the highest cancer mortality and morbidity in the world. It is already known that there is a strong association between smoking and breast cancer. However, the association between smoking and tumor severity is not very clear. The objective of this study was to assess the severity of the breast tumor, using the tumor's molecular classification as a tool according to its immunohistochemical profile in smoking and non-smoking women.


Methods: This is a longitudinal study in which 208 women with a diagnosis of breast cancer were followed for 17 months, 80 of whom were smokers and all underwent anatomopathological diagnosis by core biopsy and subsequent immunohistochemistry, followed by treatment indicated according to the type and the clinical staging of the tumor. The severity of the tumor was assessed by its molecular classification according to its immunohistochemical profile.


Results: Smoking was associated with higher mortality. The tumor with the most severe immunohistochemical profile was found in younger smokers. 19.7% of smokers had a triple negative tumor and 10% of non-smokers. The age of female smokers with triple negative was 48.2 years and of non-smoking women was 52.6 years (p = 0.005). In 17 months of follow-up, mortality among smokers was 39.5% and for nonsmokers, 20%. Survival was statistically significantly lower among the group of smokers (p=0.01).


Conclusion: smoking is associated with greater breast cancer severity, risk for cancer severity was OR 5.5 times higher for the smoking group survival was statistically significantly lower among the group of smokers

Full text article

Generated from XML file

References

ten Broeke SW, Suerink M, Nielsen M. Response to Roberts et al. 2018: is breast cancer truly caused by MSH6 and PMS2 variants or is it simply due to a high prevalence of these variants in the population? Genet Med. janeiro de 2019;21(1):256–7.

Mm G, Sm G, J S, Wr D, Lm H, Mj T. Active smoking and breast cancer risk: original cohort data and meta-analysis. J Natl Cancer Inst [Internet]. 17 de abril de 2013 [citado 2 de julho de 2024];105(8). Disponível em: https://pubmed.ncbi.nlm.nih.gov/23449445/

Gram IT, Park SY, Kolonel LN, Maskarinec G, Wilkens LR, Henderson BE, et al. Smoking and Risk of Breast Cancer in a Racially/Ethnically Diverse Population of Mainly Women Who Do Not Drink Alcohol. Am J Epidemiol. 1o de dezembro de 2015;182(11):917–25.

Cheang MCU, Chia SK, Voduc D, Gao D, Leung S, Snider J, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 20 de maio de 2009;101(10):736–50.

HMX | Harvard Medical School [Internet]. [citado 2 de julho de 2024]. HMX Pro Genetics - Cancer Genomics and Precision Oncology - Harvard Medical School. Disponível em: https://onlinelearning.hms.harvard.edu/hmx/courses/cancer-genomics/

Duda-Szymańska J, Sporny S. [The practical value of breast cancer molecular classification]. Pol Merkur Lek Organ Pol Tow Lek. julho de 2011;31(181):5–8.

Scientific TF. Next-Generation Sequencing for Pathologists [Internet]. [citado 2 de julho de 2024]. Disponível em: https://www.oncomine.com/ngs-for-pathologists

A Dominantly Inherited 5’ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer. - Abstract - Europe PMC [Internet]. [citado 9 de julho de 2024]. Disponível em: https://europepmc.org/article/pmc/6080768

He Y, Li X, Si Y, Hong J, Yu C, Gu L. The relationship between tobacco and breast cancer incidence: A systematic review and meta-analysis of observational studies. Front Oncol [Internet]. 15 de setembro de 2022 [citado 9 de julho de 2024];12. Disponível em: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.961970/full

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer | Journal of Clinical Oncology [Internet]. [citado 9 de julho de 2024]. Disponível em: https://ascopubs.org/doi/full/10.1200/JCO.2009.25.6529

Prajapati S, Martinez C, Bahadur A, Wu I, Zheng W, Lechleiter J, et al. Near-Infrared Imaging of Injured Tissue in Living Subjects Using IR-820. Mol Imaging. 1o de janeiro de 2009;8:45–54.

Darb-Esfahani S, von Minckwitz G, Denkert C, Ataseven B, Högel B, Mehta K, et al. Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes. BMC Cancer. 28 de julho de 2014;14:546.

Desrichard A, Bidet Y, Uhrhammer N, Bignon YJ. CHEK2 contribution to hereditary breast cancer in non-BRCA families. Breast Cancer Res BCR. 2011;13(6):R119.

Di Cello F, Flowers VL, Li H, Vecchio-Pagán B, Gordon B, Harbom K, et al. Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells. Mol Cancer. 6 de agosto de 2013;12(1):90.

Menezes AMB, Jardim JR, Pérez-Padilla R, Camelier A, Rosa F, Nascimento O, et al. Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO Study in São Paulo, Brazil. Cad Saúde Pública. outubro de 2005;21:1565–73.

Gaudet MM, Gapstur SM, Sun J, Diver WR, Hannan LM, Thun MJ. Active smoking and breast cancer risk: original cohort data and meta-analysis. J Natl Cancer Inst. 17 de abril de 2013;105(8):515–25.

Interaction between smoking history and gene expression levels impacts survival of breast cancer patients [Internet]. [citado 9 de julho de 2024]. Disponível em: http://ouci.dntb.gov.ua/en/works/leW8dOO7/

Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 10 de junho de 2012;30(17):2102–11.

Read “Premium Cigars: Patterns of Use, Marketing, and Health Effects” at NAP.edu [Internet]. [citado 9 de julho de 2024]. Disponível em: https://nap.nationalacademies.org/read/26421/chapter/9

Articles | Medical Oncology [Internet]. [citado 3 de julho de 2024]. Disponível em: https://link.springer.com/journal/12032/articles?page=26

Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. Smoking and Smoking Cessation in Relation to Mortality. JAMA J Am Med Assoc. 7 de maio de 2008;299(17):2037–47.

Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, et al. High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control CCC. setembro de 2002;13(7):625–35.

Authors

Greetchen Borges de Campos Bólico Ferreira
Ildo Borges de Campos Bolico Ferreira
Jamile Ahmed Borges Geha
Maria Cecília Leite de Moraes
Luciano Amorim Meirelles
Elias Ferreira Pôrto
profeliasfporto@gmail.com (Primary Contact)
1.
Ferreira GB de CB, Ferreira IB de CB, Geha JAB, Moraes MCL de, Meirelles LA, Ferreira Pôrto E. Association Between Smoking with a Molecular Profile of Breast Cancer: Smoking and molecular profile of breast cancer. Arch Breast Cancer [Internet]. 2024 Jul. 31 [cited 2024 Nov. 21];11(3). Available from: https://archbreastcancer.com/index.php/abc/article/view/938

Article Details

Similar Articles

You may also start an advanced similarity search for this article.